Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group StudyC. Lhommé, S. Pecorelli, E. Mickiewicz et al.|European Journal of Cancer|2000Cited by 43
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM. Degardin, P Cappelaere, J Chauvergne et al.|Annals of Oncology|1998Cited by 38
CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDYBrigitta G. Baumert, Roger Stupp, Monika E. Hegi et al.|Neuro-Oncology|2024Cited by 4